tiprankstipranks

Martin Edwards Insider Profile

4 Followers
Martin Edwards, Director at CoLucid Pharmaceuticals, holds 0.00 shares in CoLucid Pharmaceuticals (Ticker: CLCD), holds ― shares in KalVista Pharmaceuticals (Ticker: KALV), holds ― shares in Inozyme Pharma (Ticker: INZY). Most recently, Martin Edwards ― shares of CoLucid Pharmaceuticals on ― for an estimated value of ―.
tipranks
Martin Edwards

Martin Edwards
CoLucid Pharmaceuticals (CLCD)
Director

Not Ranked
Ranked #22,905 out of 99,335 Corporate Insiders
Martin Edwards has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
100.00%
0.00%
0.00%
A breakdown of Martin Edwards's holdings

Insider Roles

Verona Pharma
(VRNA)
Director
KalVista Pharmaceuticals
(KALV)
Director
Inozyme Pharma
(INZY)
Director
Roles that Martin Edwards holds in companies

Most Profitable Insider Trade

Stock:
Verona Pharma
(VRNA)
Rating:Informative Buy
Date:Nov 22, 2023 - Nov 22, 2024
Return:+174.50%
The most profitable trade made by Martin Edwards

Martin Edwards's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CLCD
CoLucid Pharmaceuticals
$0.00
KalVista Pharmaceuticals
Director
Inozyme Pharma
Director
RETA
Reata Pharmaceuticals
Sep 26, 2023
Uninformative Sell
$0.00
Verona Pharma
Nov 22, 2023
Director
Informative Buy
61.74K
$5.63M
MORF
Morphic Holding
Aug 21, 2024
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Martin Edwards's performance on stock

Martin Edwards insider profile FAQ

What is the percentage of profitable transactions made by Martin Edwards?
The percentage of profitable transactions made by Martin Edwards is ―.
    What is the average return per transaction made by Martin Edwards?
    The average return per transaction made by Martin Edwards is ―.
      What stocks does Martin Edwards hold?
      Martin Edwards holds: CLCD, KALV, INZY, RETA, VRNA, MORF stocks.
        What was Martin Edwards’s latest transaction?
        Martin Edwards latest transaction was an Uninformative Buy of ―.
          What was Martin Edwards's most profitable transaction?
          Martin Edwards’s most profitable transaction was an Informative Buy of VRNA stock on November 22, 2023. The return on the trade was 174.50%.
            What is Martin Edwards's role in CoLucid Pharmaceuticals?
            Martin Edwards's role in CoLucid Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.